Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,775,287
-$34,587 QoQ
Shares Held
7,664
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,107
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Investment Advisors / MI holds $15,039,322 across 11 Drug Manufacturers - General names. AMGN ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,165 | $3,564,480 | |
| 2 | LLY |
ELI LILLY & Co
|
2,376 | $2,849,845 | |
| 3 | AMGN |
Amgen Inc
This page
|
7,664 | $2,775,287 | |
| 4 | PFE |
Pfizer Inc
|
48,044 | $1,156,899 | |
| 5 | JNJ |
Johnson & Johnson
|
4,524 | $1,148,960 | |
| 6 | SNY |
Sanofi
|
25,867 | $1,103,486 | |
| 7 | MRK |
Merck & Co., Inc.
|
6,694 | $860,179 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,340 | $674,655 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,775,287 | 7,664 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,809,874 | 7,986 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,742,598 | 5,324 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,514,285 | 5,366 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $1,726,355 | 6,183 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,992,050 | 6,394 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,684,331 | 10,299 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $3,309,096 | 10,270 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,921,719 | 9,351 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,675,166 | 9,409 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,636,247 | 9,153 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,543,275 | 9,463 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,995,293 | 8,987 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,119,905 | 8,769 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,190,680 | 8,341 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,864,058 | 8,270 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $1,711,858 | 7,036 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,638,814 | 6,777 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,536,319 | 6,829 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,578,713 | 7,424 | Shares | Sole | 2021-10-19 | |
| 2021-03-31 | $1,682,204 | 6,761 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,567,746 | 11,168 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,328,748 | 5,228 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $1,049,105 | 4,448 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $870,725 | 4,295 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||